Arrowhead Pharmaceuticals · 4 days ago
Lead, Technical Transfer
Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for genetic diseases. The Lead, Technical Transfer will be responsible for leading technical transfer activities to support manufacturing readiness, including creating GMP batch records and coordinating process transfer activities across teams.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Work between process development and manufacturing scientists to create and maintain production batch records and process documentation for new and existing programs
Facilitate cross-functional coordination and input to document new methods
Manage project timelines and provide project milestone updates to internal team members
Identify and implement best practices and process improvements to technical transfer activities and documentation
Lead deviation investigations and implement appropriate corrective action as necessary
Contribute to the compilation of master data
Write SOPs pertaining to GMP production
Perform reviews of executed batch records
Work with different departments to achieve project readiness goals
Occasionally assist with laboratory work as needed
Qualification
Required
BS/BA in an applicable scientific field such as chemistry, biology, or biochemistry
3 years working in a GMP setting with a minimum of 1 year of experience in a technical writer or technical transfer position
Proficient experience working with controlled documentation
Experience with internal CAPA investigations
Proficient project management skills
Ability to collaborate with and coordinate cross-functional teams
Proficiency with Microsoft Suite applications (Word, Excel)
High attention to detail
Ability to multi-task and manage responsibilities within ongoing projects
Preferred
5+ year's GMP experience and 3+ years tech transfer experience
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-08
Company data provided by crunchbase